Monday, 24 December 2018

Live Cell Imaging Market Expected To Trigger A Revenue Increase To USD 9.0 Billion By 2025:Key Participant Carl Zeiss Meditec AG, Leica MicrosystemsCell Imaging Market


San Francisco, 24 December 2018,  Live Cell Imaging Market Analysis By Product, Application, Technology (Time lapse Microscopy, Fluorescence Recovery After Photobleaching, Fluorescence Resonance Energy Transfer, High Content Screening), & Segment Forecasts, 2018 – 2025

The global live cell imaging market is expected to reach USD 9.0 billion by 2025, according to a new report by Grand View Research, Inc. Rising popularity of kinetic research over fixed cellular analysis is the key driver. Addition of dyes and reagents alter the cell behavior, mostly in a negative manner, which does not showcase the natural course of action of the cellular functions. Understanding the cellular behavior in its natural state is crucial in drug discovery and targeted drug therapy. This, in turn, increases the need for live cell imaging, thus boosting the market.
In a survey by Drug Discovery World Spring, almost 21% researchers prefer & use live cell imaging and 31% plan to use it in the future. Moreover, 38% of the respondents were interested in using live cell kinetic HCS imaging in the future. The most important feature for researchers is the ability to automate the incubation and image capturing of any live cell analyzer. Secondly, they also give importance to viable cell-tracking ability of the equipment. Further development in the technology of equipment is expected to fulfill these criteria and boost the utility of the same over the forecast period.
Development in delivering probes in living cells, targeting organelles, and proteins using some of the techniques has increased use and adoption of live cell imaging in research and other applications. With improved fluorescent probes, the techniques such as Fluorescence Resonance Energy Transfer (FRET) share a majority of the share.
Access Full Research Report On Live Cell Imaging Market  Analysis:
www.grandviewresearch.com/industry-analysis/live-cell-imaging-market

Further Key Findings From The Report Suggest:
·         Equipment dominated the product segment in 2016. The current system, although of great potential are still expected to perform better over the next few years. The general trend is to make the instruments compact and integrated for end-to-end processing.
·         Cell biology dominated the application with more than 30% of the shares and was closely followed by developmental biology. Stem cell and drug discovery are the upcoming fields to apply live cell imaging in the research.
·         North America dominated due to its high investment rate and technologically sound infrastructure. The research firms present in this region are technologically aware, hence, readily invest in high cost equipment.
·         Asia Pacific is expected to show fastest growth over the forecast period due to increasing application of these imaging techniques in drug discovery and personalized medicine.
·         Key players includes Carl Zeiss Meditec AG; Leica Microsystems; Nikon Corporation; Becton, Dickinson and Company; GE Healthcare; Olympus Corporation; Thermo Fisher Scientific Inc.; Sigma-Aldrich Corporation; PerkinElmer, Inc.; and Molecular Devices, LLC
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the global live cell imaging market on the basis of product, application, technology, and region:
Live Cell Imaging Product Outlook (Revenue, USD Million, 2014 - 2025)
·         Equipment
·         Consumable
·         Software
Live Cell Imaging Application Outlook (Revenue, USD Million, 2014 - 2025)
·         Cell Biology
·         Developmental Biology
·         Stem Cell & Drug Discovery
·         Others
Live Cell Imaging Technology Outlook (Revenue, USD Million, 2014 - 2025)
·         Time lapse Microscopy
·         Fluorescence recovery after photobleaching (FRAP)
·         Fluorescence resonance energy transfer (FRET)
·         High content screening (HCS)
·         Others
Live Cell Imaging Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    UK
o    Germany
·         Asia Pacific
o    China
o    Japan
·         Latin America
o    Brazil
o    Mexico
·         MEA
o    South Africa 

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/

Cystic Fibrosis Therapeutics Market Expected To Trigger A Revenue Increase To USD 13.9 Billion By 2025:Key Participant AbbVie Inc., F. Hoffmann-La Roche Ltd.


San Francisco, 24 December 2018,  Cystic Fibrosis (CF) Therapeutics Market Analysis By Drug Class (Pancreatic Enzyme Supplements, Mucolytics, Bronchodilators, CFTR Modulators), By Route of Administration, By Region, And Segment Forecasts, 2018 - 2025

The global cysticfibrosis therapeutics market is expected to reach USD 13.9 billion by 2025, according to a new report by Grand View Research, Inc. The rising prevalence of Cystic Fibrosis (CF) globally, research & development activities undertaken by key players, and favorable initiatives undertaken by nonprofit organizations are expected to boost the market over the forecast period.
The rising prevalence of CF indicates the rising demand for treatment alternatives, thereby uplifting the market. The key players operating in this market in collaboration with nonprofit organizations focus on the development of novel therapeutics for treatment. Some of the drugs that are under clinical studies are VX-445 + tezacaftor + ivacaftor, PTI-428, QR-010, AZD5634, and POL6014.
Favorable initiatives taken by regional and national nonprofit organizations is one of the key factors propelling growth. These initiatives ensure support to CF patients. These organizations aid in research & development activities of these therapeutics and help improve the quality of life of these patients. For instance, North American Cystic Fibrosis Conference (NACFC) was formed in 1986 to provide a collaborative and educational forum to CF professionals to share advances in R&D related to CF therapeutics.
Access Full Research Report On Cystic Fibrosis (CF) Therapeutics Market  Analysis:
www.grandviewresearch.com/industry-analysis/cystic-fibrosis-cf-therapeutics-market

Further key findings from the report suggest:
·         The global CF therapeutics market size was estimated at USD 3,560.5 million in 2016 and is expected to grow at a CAGR of 16.7% from 2017 to 2025
·         The CFTR modulator segment emerged as the largest segment in 2016 and the same segment is anticipated to witness fastest growth over the next 8 years owing to the approval of CFTR modulator, Orkambi and the presence of various investigational compounds under the pipeline.
·         Oral route of administration emerged as the largest segment with revenue of USD 2,266.4 million due to the ease of administration and convenience
·         North America accounted for the largest market share owing to the presence of Caucasian descents in this region. Improved healthcare infrastructure, reimbursements, and initiatives undertaken by the nonprofit organizations is expected to propel the market over forecast period,
·         The key players include AbbVie Inc., F. Hoffmann-La Roche Ltd.; Gilead, Novartis AG, Vertex Pharmaceuticals Inc., AIT (Advanced Inhalation Therapies), Alaxia, Teva Pharmaceutical Industries Ltd, Merck & Co. Inc., Alcresta Therapeutics Inc., Allergan, and AstraZeneca
Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the cystic fibrosis therapeutics market on the basis of drug class, route of administration and region:
Cystic Fibrosis Therapeutics Drug Class Outlook (Revenue, USD Million, 2014 - 2025)
·         Pancreatic enzyme supplements
·         Mucolytics
·         Bronchodilators
·         CFTR modulators
Cystic Fibrosis Therapeutics Route of Administration Outlook (Revenue, USD Million, 2014 - 2025)
·         Oral drugs
·         Inhaled drugs
Cystic Fibrosis Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    Japan
·         Latin America
o    Brazil
o    Mexico
·         Middle East & Africa
o    South Africa


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/


Silver Nanoparticles Market Expected To Trigger A Revenue Increase To USD 2.45 Billion By 2022:Key Participant Emfutur Technologies


San Francisco, 24 December 2018, Silver Nanoparticles Market By Application (Electronics & Electrical, Healthcare, Food & Beverages, Textiles) And Segment Forecasts To 2022


Global silver nanoparticles market is expected to reach USD 2.45 billion by 2022, according to a new study by Grand View Research, Inc. Rising demand for antimicrobial materials in healthcare applications is expected to drive silver nanoparticles market over the forecast period. Development of high-end electronics coupled with growing demand for gadgets is expected to promote silver nanoparticle market growth over the next seven years.
Healthcare was the largest application segment, accounting for over 30% of global silver nanoparticles market revenue in 2014. Growth of the healthcare market on account of growing consumer awareness regarding general well-being, increasing geriatric population and rise in disposable income is expected to augment silver nanoparticles market. Increasing demand for antimicrobial textiles on account of rising consumer awareness regarding hygiene is anticipated to stimulate market growth.
Access Full Research Report On Silver Nanoparticles Analysis:

Further key findings from the study suggest:
·         Increasing application scope of silver nanoparticles in transparent conductors, which are widely used in touch screens, LED & OLED display and lighting coupled with growing demand for high-end gadgets is expected to drive market growth
·         North America dominated the global silver nanoparticles market in 2014 accounting for over 35% of the market in terms of volume and the trend is anticipated to continue over the forecast period. Rising awareness regarding prevention of hospital acquired diseases is expected to play an important role in promoting silver nanoparticles use in medical devices & equipment and textiles
·         Increasing application scope of silver nanoparticles in children’s toys in order to reduce spread of diseases by minimizing surface antimicrobial activities is expected to open new opportunities for market growth over the forecast period
·         Emergence of nanofinished textiles for odor control and curb growth of infection causing bacteria is expected to propel silver nanoparticles market demand
·         Presence of stringent regulatory framework, particularly in North America and Europe, is anticipated to hamper silver nanoparticles market. Furthermore, numerous studies have been undertaken to ascertain harmful effects of nanosilver to the environment, which is further anticipated to restrain market growth.
·         Key players present in the global silver nanoparticle market include Emfutur Technologies, Meliorum Technologies Inc, Nanoshel, NanoHorizons and Cline Scientific AB. The market is characterized by companies developing proprietary manufacturing technologies. For instance, Cima Nanotech developed SANTE (Self Assembling Nanotech Technology), an innovative self-assembling coating material.
Browse More Reports Of This Category By Grand View Research At:   www.grandviewresearch.com/industry/nanoparticles
Grand View Research has segmented the global silver nanoparticles market on the basis of application and region:
Global Silver Nanoparticles Application Outlook (Volume, Tons; Revenue, USD Million, 2012 - 2022)
·         Electronics & electrical
·         Healthcare
·         Food & beverages
·         Textiles
·         Others
Global Silver Nanoparticles Regional Outlook (Volume, Tons; Revenue, USD Million, 2012 - 2022)
·         North America
o    U.S.
·         Europe
o    Germany
o    UK
·         Latin America
·         Asia Pacific
o    China
o    South Korea
·         MEA


About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com/